Skip to main content
. 2020 Oct 10;5(1):74–82. doi: 10.1002/hep4.1614

Table 1.

Clinical Characteristics of the Study Sample by Hepatic Steatosis Status

Clinical Characteristics* Hepatic Steatosis (n = 479) No Hepatic Steatosis (n = 2,294) Overall (N = 2,773)
Age (years) 52 ± 11 51 ± 10 51 ± 11
Women, n (%) 266 (55.5%) 1,077 (46.9%) 1,343 (48.9%)
Third Generation cohort, n (%) 274 (57.2%) 1,421 (61.9%) 1,695 (61.1%)
Current smoking, n (%) 51 (10.6%) 257 (11.2%) 308 (11.1%)
BMI (kg/m2) 28.7 (0.17) 26.5 (0.16) 26.4 (0.19)
Ideal (<25 kg/m2) 49 (10.2%) 916 (39.9%) 965 (34.8%)
Intermediate (25 to <30 kg/m2) 169 (35.3%) 931 (40.6%) 1,100 (39.7%)
Poor (≥30 kg/m2) 261 (54.5%) 447 (19.5%) 708 (25.5%)
PAI
Ideal (PAI ≥75th percentile) 111 (23.2%) 599 (26.1%) 710 (25.6%)
Intermediate (PAI 25th‐74th percentile) 236 (49.3%) 1,145 (49.9%) 1,381 (49.8%)
Poor (PAI <25th percentile) 132 (27.6%) 550 (24.0%) 682 (24.6%)
Total cholesterol
Ideal (<200 mg/dL without treatment) 257 (53.7%) 1,344 (58.6%) 1,601 (57.7%)
Intermediate (200‐239 mg/dL or treated) 161 (33.6%) 726 (31.6%) 887 (35.0%)
Poor (≥240 mg/dL) 61 (12.7%) 224 (9.8%) 285 (10.3%)
Blood pressure
Ideal (SBP <120 mm Hg and DBP <80 mm Hg without treatment) 118 (24.6%) 1,128 (49.2%) 1,246 (44.9%)
Intermediate (SBP 120‐139 mm Hg, DBP 80‐89 mm Hg, or treated) 328 (68.5%) 1,077 (46.9%) 1,405 (50.7%)
Poor (SBP ≥140 mm Hg or DBP ≥90 mm Hg) 33 (6.9%) 89 (3.9%) 122 (4.4%)
Blood sugar
Ideal (<100 mg/dL without treatment) 216 (45.1%) 1,678 (73.1%) 1,894 (68.3%)
Intermediate (100‐125 mg/dL or treated) 75 (3.3%) 541 (23.6%) 755 (27.2%)
Poor (≥126 mg/dL) 49 (10.2%) 75 (3.3%) 124 (4.5%)
AHA Life’s Simple 7 2 ± 1 3 ± 1 3 ± 1
*

Clinical characteristics are represented as mean ± SD or n (%).

Abbreviations: AHA, American Heart Association; BMI, body mass index; DBP, diastolic blood pressure; PAI, physical activity index; SBP, systolic blood pressure.